Global Spread of SARS-CoV-2 Subtype with Spike Protein Mutation D614G is Shaped by Human Genomic Variations that Regulate Expression of TMPRSS2 and MX1 Genes
暂无分享,去创建一个
Animesh K. Singh | P. Majumder | Arnab Ghosh | N. Biswas | A. Basu | S. Mukherjee | Chitrarpita Das | Chandrika Bhattacharyya
[1] P. Majumder,et al. Analysis of RNA sequences of 3636 SARS-CoV-2 collected from 55 countries reveals selective sweep of one virus type , 2020, The Indian journal of medical research.
[2] Hans Clevers,et al. SARS-CoV-2 productively infects human gut enterocytes , 2020, Science.
[3] R. Woods,et al. Neutrophil extracellular traps in COVID-19. , 2020, JCI insight.
[4] David S. Fischer,et al. Integrated analyses of single-cell atlases reveal age, gender, and smoking status associations with cell type-specific expression of mediators of SARS-CoV-2 viral entry and highlights inflammatory programs in putative target cells , 2020, bioRxiv.
[5] Kari Stefansson,et al. Spread of SARS-CoV-2 in the Icelandic Population , 2020, The New England journal of medicine.
[6] Kyle J. Gaulton,et al. Single Nucleus Multiomic Profiling Reveals Age-Dynamic Regulation of Host Genes Associated with SARS-CoV-2 Infection , 2020, bioRxiv.
[7] Frederic A. Fellouse,et al. Human ACE2 receptor polymorphisms predict SARS-CoV-2 susceptibility , 2020, bioRxiv.
[8] Yan Zhao,et al. Neutrophil-to-lymphocyte ratio as an independent risk factor for mortality in hospitalized patients with COVID-19 , 2020, Journal of Infection.
[9] T. Skoff,et al. Coronavirus Disease 2019 in Children — United States, February 12–April 2, 2020 , 2020, MMWR. Morbidity and mortality weekly report.
[10] Colin Renfrew,et al. Phylogenetic network analysis of SARS-CoV-2 genomes , 2020, Proceedings of the National Academy of Sciences.
[11] K. Yuen,et al. Structural and Functional Basis of SARS-CoV-2 Entry by Using Human ACE2 , 2020, Cell.
[12] Tartaglia Marco,et al. ACE2 variants underlie interindividual variability and susceptibility to COVID-19 in Italian population , 2020, medRxiv.
[13] F. A. Lagunas-Rangel. Neutrophil‐to‐lymphocyte ratio and lymphocyte‐to‐C‐reactive protein ratio in patients with severe coronavirus disease 2019 (COVID‐19): A meta‐analysis , 2020, Journal of medical virology.
[14] Morteza Abdullatif Khafaie,et al. Cross-Country Comparison of Case Fatality Rates of COVID-19/SARS-COV-2 , 2020, Osong public health and research perspectives.
[15] Xiliang Wang,et al. COVID-19: a new challenge for human beings , 2020, Cellular & Molecular Immunology.
[16] Jarek Kobiela,et al. Estimating case fatality rates of COVID-19 , 2020, The Lancet Infectious Diseases.
[17] C. Whittaker,et al. Estimates of the severity of coronavirus disease 2019: a model-based analysis , 2020, The Lancet Infectious Diseases.
[18] Lanjuan Li,et al. SARS-CoV-2: virus dynamics and host response , 2020, The Lancet Infectious Diseases.
[19] G. Onder,et al. Case-Fatality Rate and Characteristics of Patients Dying in Relation to COVID-19 in Italy. , 2020, JAMA.
[20] Jin Tian,et al. COVID-19: Epidemiology, Evolution, and Cross-Disciplinary Perspectives , 2020, Trends in Molecular Medicine.
[21] E. Holmes,et al. The proximal origin of SARS-CoV-2 , 2020, Nature Medicine.
[22] Fumihiro Kato,et al. Enhanced isolation of SARS-CoV-2 by TMPRSS2-expressing cells , 2020, Proceedings of the National Academy of Sciences.
[23] R. Lu,et al. Detection of SARS-CoV-2 in Different Types of Clinical Specimens. , 2020, JAMA.
[24] A. Walls,et al. Structure, Function, and Antigenicity of the SARS-CoV-2 Spike Glycoprotein , 2020, Cell.
[25] G. Herrler,et al. SARS-CoV-2 Cell Entry Depends on ACE2 and TMPRSS2 and Is Blocked by a Clinically Proven Protease Inhibitor , 2020, Cell.
[26] A. M. Leontovich,et al. The species Severe acute respiratory syndrome-related coronavirus: classifying 2019-nCoV and naming it SARS-CoV-2 , 2020, Nature Microbiology.
[27] Chuan Qin,et al. Dysregulation of immune response in patients with COVID-19 in Wuhan, China , 2020, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[28] P. Horby,et al. A novel coronavirus outbreak of global health concern , 2020, The Lancet.
[29] G. Gao,et al. A Novel Coronavirus from Patients with Pneumonia in China, 2019 , 2020, The New England journal of medicine.
[30] A. Mócsai,et al. Neutrophils as emerging therapeutic targets , 2020, Nature Reviews Drug Discovery.
[31] Phillip A. Richmond,et al. JASPAR 2020: update of the open-access database of transcription factor binding profiles , 2019, Nucleic Acids Res..
[32] R. Rabin,et al. IRF1 Maintains Optimal Constitutive Expression of Antiviral Genes and Regulates the Early Antiviral Response , 2019, Front. Immunol..
[33] Sara R. Selitsky,et al. Basal expression of interferon regulatory factor 1 drives intrinsic hepatocyte resistance to multiple RNA viruses , 2019, Nature Microbiology.
[34] Lu Lu,et al. A pan-coronavirus fusion inhibitor targeting the HR1 domain of human coronavirus spike , 2019, Science Advances.
[35] C. D. Dela Cruz,et al. BPIFA1 regulates lung neutrophil recruitment and interferon signaling during acute inflammation. , 2019, American journal of physiology. Lung cellular and molecular physiology.
[36] Gholamreza Haffari,et al. PROSPERous: high-throughput prediction of substrate cleavage sites for 90 proteases with improved accuracy , 2018, Bioinform..
[37] K. Shirato,et al. Wild-type human coronaviruses prefer cell-surface TMPRSS2 to endosomal cathepsins for cell entry , 2017, Virology.
[38] J. Nyengaard,et al. The TLR9 agonist MGN1703 triggers a potent type I interferon response in the sigmoid colon , 2017, Mucosal Immunology.
[39] Trevor Bedford,et al. Nextstrain: real-time tracking of pathogen evolution , 2017, bioRxiv.
[40] Kimberly J. Hassett,et al. Efficient Targeting and Activation of Antigen-Presenting Cells In Vivo after Modified mRNA Vaccine Administration in Rhesus Macaques , 2017, Molecular therapy : the journal of the American Society of Gene Therapy.
[41] S. Kotenko,et al. Interferon‐&lgr; Mediates Non‐redundant Front‐Line Antiviral Protection against Influenza Virus Infection without Compromising Host Fitness , 2017, Immunity.
[42] Yuelong Shu,et al. GISAID: Global initiative on sharing all influenza data – from vision to reality , 2017, Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin.
[43] C. Johansson,et al. Type I Interferons as Regulators of Lung Inflammation , 2017, Front. Immunol..
[44] J. Homola,et al. The Scavenger Receptor SSc5D Physically Interacts with Bacteria through the SRCR-Containing N-Terminal Domain , 2016, Front. Immunol..
[45] S. Perlman,et al. Proteolytic processing of Middle East respiratory syndrome coronavirus spikes expands virus tropism , 2016, Proceedings of the National Academy of Sciences.
[46] B. Schilling,et al. Type I IFNs induce anti‐tumor polarization of tumor associated neutrophils in mice and human , 2016, International journal of cancer.
[47] Latarsha J. Carithers,et al. The Genotype-Tissue Expression (GTEx) Project. , 2015, Biopreservation and biobanking.
[48] Kairong Cui,et al. Division of labor between IRF1 and IRF2 in regulating different stages of transcriptional activation in cellular antiviral activities , 2015, Cell & Bioscience.
[49] A. von Haeseler,et al. IQ-TREE: A Fast and Effective Stochastic Algorithm for Estimating Maximum-Likelihood Phylogenies , 2014, Molecular biology and evolution.
[50] Carson C Chow,et al. Second-generation PLINK: rising to the challenge of larger and richer datasets , 2014, GigaScience.
[51] Mark A. Miller,et al. Neutrophil Elastase Causes Tissue Damage That Decreases Host Tolerance to Lung Infection with Burkholderia Species , 2014, PLoS pathogens.
[52] Bo-guang Sun,et al. Identification and characterization of a cell surface scavenger receptor cysteine-rich protein of Sciaenops ocellatus: bacterial interaction and its dependence on the conserved structural features of the SRCR domain. , 2013, Fish & shellfish immunology.
[53] Trevor Bedford,et al. Viral Phylodynamics , 2013, PLoS Comput. Biol..
[54] K. Katoh,et al. MAFFT Multiple Sequence Alignment Software Version 7: Improvements in Performance and Usability , 2013, Molecular biology and evolution.
[55] Christophe Fraser,et al. Integrating Phylodynamics and Epidemiology to Estimate Transmission Diversity in Viral Epidemics , 2013, PLoS Comput. Biol..
[56] Geoffrey I. Webb,et al. PROSPER: An Integrated Feature-Based Tool for Predicting Protease Substrate Cleavage Sites , 2012, PloS one.
[57] A. Tsung,et al. Interferon regulatory factor-2 is protective against hepatic ischemia-reperfusion injury. , 2012, American journal of physiology. Gastrointestinal and liver physiology.
[58] S. Moestrup,et al. The Conserved Scavenger Receptor Cysteine-Rich Superfamily in Therapy and Diagnosis , 2011, Pharmacological Reviews.
[59] Heng Li,et al. Tabix: fast retrieval of sequence features from generic TAB-delimited files , 2011, Bioinform..
[60] H. Hakonarson,et al. ANNOVAR: functional annotation of genetic variants from high-throughput sequencing data , 2010, Nucleic acids research.
[61] Yang Zhang,et al. I-TASSER: a unified platform for automated protein structure and function prediction , 2010, Nature Protocols.
[62] Markus Eickmann,et al. Cleavage of Influenza Virus Hemagglutinin by Airway Proteases TMPRSS2 and HAT Differs in Subcellular Localization and Susceptibility to Protease Inhibitors , 2010, Journal of Virology.
[63] Christopher D. Paddock,et al. Cellular Immune Responses to Severe Acute Respiratory Syndrome Coronavirus (SARS-CoV) Infection in Senescent BALB/c Mice: CD4+ T Cells Are Important in Control of SARS-CoV Infection , 2009, Journal of Virology.
[64] Pablo Librado,et al. DnaSP v5: a software for comprehensive analysis of DNA polymorphism data , 2009, Bioinform..
[65] G. Whittaker,et al. Activation of the SARS coronavirus spike protein via sequential proteolytic cleavage at two distinct sites , 2009, Proceedings of the National Academy of Sciences.
[66] C. Hsiao,et al. Modeling the Early Events of Severe Acute Respiratory Syndrome Coronavirus Infection In Vitro , 2006, Journal of Virology.
[67] David E. Swayne,et al. Characterization of the Reconstructed 1918 Spanish Influenza Pandemic Virus , 2005, Science.
[68] S. Morikawa,et al. Protease-mediated enhancement of severe acute respiratory syndrome coronavirus infection. , 2005, Proceedings of the National Academy of Sciences of the United States of America.
[69] Xi Rao,et al. Identification of Two Critical Amino Acid Residues of the Severe Acute Respiratory Syndrome Coronavirus Spike Protein for Its Variation in Zoonotic Tropism Transition via a Double Substitution Strategy , 2005, Journal of Biological Chemistry.
[70] J. R. Somoza,et al. The structure of the extracellular region of human hepsin reveals a serine protease domain and a novel scavenger receptor cysteine-rich (SRCR) domain. , 2003, Structure.
[71] H. Ohbayashi. Neutrophil elastase inhibitors as treatment for COPD , 2002, Expert opinion on investigational drugs.
[72] M. Gordon,et al. Expression of interferon regulatory factor (IRF) genes and response to interferon-α in chronic myeloid leukaemia , 1997, Leukemia.
[73] Sudhir Kumar,et al. MEGA: Molecular Evolutionary Genetics Analysis software for microcomputers , 1994, Comput. Appl. Biosci..
[74] F. Tajima. Statistical method for testing the neutral mutation hypothesis by DNA polymorphism. , 1989, Genetics.
[75] Takashi Miyata,et al. Structurally similar but functionally distinct factors, IRF-1 and IRF-2, bind to the same regulatory elements of IFN and IFN-inducible genes , 1989, Cell.
[76] B. Weir,et al. ESTIMATING F‐STATISTICS FOR THE ANALYSIS OF POPULATION STRUCTURE , 1984, Evolution; international journal of organic evolution.